Published in Healthcare Mergers, Acquisitions and Ventures Week, March 7th, 2009
“We had a strong finish to 2008, reporting record revenue for the fourth quarter. Domestic product revenue grew 35% compared with the 2007 fourth quarter and reflected initial sales from our suprarenal proximal extensions and Powerlink XL® introduced late last year. Feedback regarding these new products has been very positive,” said John McDermott, Endologix President and Chief Executive Officer. “We exceeded...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.